|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7088 | (2006.01) |
| A61K 31/7125 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 7/06 | (2006.01) |
| (11) | Number of the document | 3646876 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19187756.2 |
| Date of filing the European patent application | 2013-11-15 | |
| (97) | Date of publication of the European application | 2020-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-14 |
| (46) | Date of publication of the claims translation | 2024-05-10 |
| (30) | Number | Date | Country code |
| 201261734941 P | 2012-12-07 | US | |
| 201361799069 P | 2013-03-15 | US | |
| 201313841711 | 2013-03-15 | US | |
| 201361900347 P | 2013-11-05 | US |
| (72) |
STUART, Monic, J. , US
KELSEY, Stephen , US
|
| (73) |
Geron Corporation ,
919 E. Hillsdale Blvd., Suite 250, Foster City, CA 94404,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Telomerazės inhibitorius imetelstatas, skirtas mieloproliferacinių sutrikimų ir mieloproliferacinių navikų gydymui |
| THE TELOMERASE INHIBITOR IMETELSTAT FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS AND MYELOPROLIFERATIVE NEOPLASMS |
| Payment date | Validity (years) | Amount | |
| 2024-09-26 | 12 | 289.00 EUR |
| 2025-11-15 |